Sight Sciences Inc.

11/06/2025 | Press release | Distributed by Public on 11/06/2025 15:32

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Rodberg James
2. Date of Event Requiring Statement (Month/Day/Year)
11/05/2025
3. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [SGHT]
(Last) (First) (Middle)
C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
MENLO PARK, CA 94025
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 146,026(1) D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (2) 05/24/2031 Common Stock 27,500 $10.96 D
Stock Option (Right to Buy) (3) 02/08/2032 Common Stock 13,100 $17.52 D
Stock Option (Right to Buy) (4) 03/16/2033 Common Stock 14,400 $9.78 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Rodberg James
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100
MENLO PARK, CA 94025
Chief Financial Officer

Signatures

/s/Jeremy Hayden, Attorney-in-Fact for James Rodberg 11/06/2025
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes (i) 28,252 shares of Common Stock, and (ii) 117,774 restricted stock units which are subject to vesting conditions.
(2) These options were granted on May 25, 2021 and became exercisable as to 25% of the underlying securities May 16, 2022, with the remainder vesting in 36 substantially equal installments on a monthly basis thereafter, subject to the Reporting Person's continued service to the Company through each such date.
(3) These options were granted on February 9, 2022 and vest in 48 substantially equal installments on a monthly basis commencing February 1, 2022, subject to the Reporting Person's continued service to the Company through each such date.
(4) These options were granted on March 16, 2023 and vest in 48 substantially equal installments on a monthly basis commencing February 1, 2023, subject to the Reporting Person's continued service to the Company through each such date.

Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Sight Sciences Inc. published this content on November 06, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on November 06, 2025 at 21:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]